Literature DB >> 1104550

The binding of kasugamycin to the Escherichia coli ribosomes.

A Okuyama, N Tanaka, T Komai.   

Abstract

The binding of kasugamycin to the E. coli ribosomes has been demonstrated by equilibrium dialysis. Kasugamycin binds to the 70S ribosomes in a molar ratio of 1:1. The association constant is approximately 6 X 10(-4) M-1. The antibiotic binds to the 30S subunit as well as to 70S ribosomes, but only slightly to the 50S subunit. The binding of kasugamycin is not significantly affected by the presence of other aminolgycoside antibiotics: streptomycin, kanamycin. or gentamicin. Kasugamycin does not bind to ribosomes derived from a kasugamycin-resistant mutant, ksgC.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1104550     DOI: 10.7164/antibiotics.28.903

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  5 in total

1.  Mechanism of action of habekacin, a novel amino acid-containing aminoglycoside antibiotic.

Authors:  N Tanaka; K Matsunaga; A Hirata; Y Matsuhisa; T Nishimura
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

2.  The ribosomal components responsible for kasugamycin dependence, and its suppression, in a mutant of Escherichia coli.

Authors:  E R Dabbs
Journal:  Mol Gen Genet       Date:  1980-01

3.  Structural analysis of kasugamycin inhibition of translation.

Authors:  Barbara S Schuwirth; J Michael Day; Cathy W Hau; Gary R Janssen; Albert E Dahlberg; Jamie H Doudna Cate; Antón Vila-Sanjurjo
Journal:  Nat Struct Mol Biol       Date:  2006-09-24       Impact factor: 15.369

4.  Effects of Kasugamycin on the Translatome of Escherichia coli.

Authors:  Christian Lange; Matthias Lehr; Karolin Zerulla; Petra Ludwig; Jens Schweitzer; Tino Polen; Volker F Wendisch; Jörg Soppa
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

5.  A Novel Method to Evaluate Ribosomal Performance in Cell-Free Protein Synthesis Systems.

Authors:  Noémie Kempf; Cristina Remes; Ralph Ledesch; Tina Züchner; Henning Höfig; Ilona Ritter; Alexandros Katranidis; Jörg Fitter
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.